Medication info
Roset Tablet 10/10 mg

Roset Tablet 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
White to almost white round film-coated tablet
Packaging
30 tablets (10 tablets/PTP X 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201601217 · Approved 2016.02.29 · Insurance code 649807080

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL-cholesterol
  • increased Apo B protein
  • increased triglycerides
  • increased non-HDL cholesterol
  • increased risk of atherogenic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
View approved original text

This medication is used as an adjunct therapy to lower elevated total cholesterol, LDL-cholesterol, Apo B, triglycerides, and non-HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing the good cholesterol HDL-cholesterol. It is primarily administered in conjunction with a dietary regimen, particularly when diet alone is insufficient. It is especially effective in patients at high risk of atherogenic vascular disease due to hypercholesterolemia. Before using the medication, secondary causes such as diabetes or hypothyroidism must be confirmed, and treatment for these should be administered if necessary. To accurately assess lipid levels, tests for total cholesterol, LDL, HDL, and triglycerides are essential, and lipid testing is recommended during cardiovascular incident hospitalizations. This drug safely and effectively aids in the improvement of dyslipidemia.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause a rare side effect known as rhabdomyolysis, which may result in severe muscle problems. Consequently, acute renal failure may occur, so if severe muscle pain or weakness is experienced, medical consultation should be sought immediately. This medication should not be administered to patients with certain conditions. For example, individuals allergic to this drug, those with active liver disease, muscle disorders, severe renal failure, or women who are pregnant or breastfeeding should not take this medication. Patients with alcohol dependence, impaired liver function, the elderly, or those with hypothyroidism, all of whom are at increased risk for myopathy, should use this medication cautiously and require regular monitoring of muscle and liver function. This drug can place stress on the liver; therefore, dosage adjustments or discontinuation should occur if liver function tests yield abnormal results. Treatment should be discontinued immediately if symptoms such as hepatitis or jaundice appear. Blood glucose levels may increase while taking this medication, so patients at risk of diabetes should monitor their blood sugar regularly. Caution is required when used in conjunction with other medications. In particular, concomitant use with certain antibiotics, antifungals, immunosuppressants, anticoagulants, and fibrates may increase the risk of side effects from this medication, warranting consultation with a physician. Women who are pregnant or planning to become pregnant should not take this medication, and effective contraceptive methods should be used during treatment. It is also advisable that breastfeeding women refrain from using this drug. The safety of this medication in children and adolescents has not been adequately established, so its use is generally not recommended except in special cases. During treatment with this medication, dizziness or drowsiness may occur, necessitating caution when driving or operating machinery. Due to the presence of lactose, patients with lactose intolerance or related genetic disorders should not take this medication. In case of overdose, there is no specific antidote, so appropriate treatment and supportive care based on symptoms should be received, along with regular monitoring of liver function and muscle enzyme levels. This medication should be kept out of reach of children and it is advisable not to transfer it to other containers.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, increased blood bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, abnormal sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, weakness, fatigue, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, thrombocytopenia, increased blood creatinine, acute renal failure, oliguria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a well-closed container to avoid exposure to air or moisture, and the temperature should be kept between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White to almost white round film-coated tablet

Package unit

30 tablets (10 tablets/PTP X 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.